We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ashland to Hike Price of Maleic Anhydride in North America
Read MoreHide Full Article
Ashland Global Holdings Inc. (ASH - Free Report) declared that it will raise the price of maleic anhydride sold in North America by 4 cents per lb. The price increase will be effective from Nov 1 or as contracts permit.
According to Ashland, the price hike is due to the spike in costs of major raw materials. The move is expected to ensure effective service to customers both in terms of quality and performance along with the ability to reinvest in the company’s product line.
Shares of Ashland have decreased 42.6% over a year, underperforming the industry’s 12.7% gain.
Ashland reported a net loss from continuing operations of $16 million or 26 cents per share in third-quarter fiscal 2017 (ended Jun 30), against a net income of $24 million or 38 cents in the year-ago period. Barring one-time items, adjusted earnings were 83 cents per share which beat the Zacks Consensus Estimate of 70 cents.
According to Ashland, the Specialty Ingredients unit recorded 7% year-over-year increase in revenues while sales of Composites grew by 20% on the back of disciplined pricing and robust volume expansions in various global end markets. Intermediates and Solvents unit also witnessed 9% increase in sales owing to continued recovery in butanediol pricing and improving global demand.
Ashland closed the acquisition of Pharmachem Laboratories, Inc., in May. The acquisition was a key contributor to Ashland’s sales in the third quarter. The company expects to achieve meaningful cost synergies from leveraging combined capabilities along with tax synergies resulting from Pharmachem integration.
Some better-ranked stocks in the chemical space are The Chemours Company (CC - Free Report) , FMC Corporation (FMC - Free Report) and Air Products and Chemicals, Inc. (APD - Free Report) .
FMC has expected long-term earnings growth of 11.3% and flaunts a Zacks Rank #1.
Air Products has expected long-term earnings growth of 12.1% and carries a Zacks Rank #2 (Buy).
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Ashland to Hike Price of Maleic Anhydride in North America
Ashland Global Holdings Inc. (ASH - Free Report) declared that it will raise the price of maleic anhydride sold in North America by 4 cents per lb. The price increase will be effective from Nov 1 or as contracts permit.
According to Ashland, the price hike is due to the spike in costs of major raw materials. The move is expected to ensure effective service to customers both in terms of quality and performance along with the ability to reinvest in the company’s product line.
Shares of Ashland have decreased 42.6% over a year, underperforming the industry’s 12.7% gain.
Ashland reported a net loss from continuing operations of $16 million or 26 cents per share in third-quarter fiscal 2017 (ended Jun 30), against a net income of $24 million or 38 cents in the year-ago period. Barring one-time items, adjusted earnings were 83 cents per share which beat the Zacks Consensus Estimate of 70 cents.
According to Ashland, the Specialty Ingredients unit recorded 7% year-over-year increase in revenues while sales of Composites grew by 20% on the back of disciplined pricing and robust volume expansions in various global end markets. Intermediates and Solvents unit also witnessed 9% increase in sales owing to continued recovery in butanediol pricing and improving global demand.
Ashland closed the acquisition of Pharmachem Laboratories, Inc., in May. The acquisition was a key contributor to Ashland’s sales in the third quarter. The company expects to achieve meaningful cost synergies from leveraging combined capabilities along with tax synergies resulting from Pharmachem integration.
Ashland Global Holdings Inc. Price and Consensus
Ashland Global Holdings Inc. Price and Consensus | Ashland Global Holdings Inc. Quote
Zacks Rank & Stocks to Consider
Ashland currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the chemical space are The Chemours Company (CC - Free Report) , FMC Corporation (FMC - Free Report) and Air Products and Chemicals, Inc. (APD - Free Report) .
Chemours has expected long-term earnings growth of 15.5% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FMC has expected long-term earnings growth of 11.3% and flaunts a Zacks Rank #1.
Air Products has expected long-term earnings growth of 12.1% and carries a Zacks Rank #2 (Buy).
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>